("Arecor", the "Company" or the "Group")
Director/PDMR Dealing
|
|
Number of Ordinary Shares purchased |
Price (£) |
Total beneficial interest (Ordinary Shares) |
Total beneficial interest (%) |
|
|
31,750 |
0.4697 |
318,361 |
0.84% |
|
|
21,077 |
0.4697 |
905,481 |
2.40% |
|
|
10,000 |
0.4700 |
417,808 |
1.11% |
-ENDS-
For more information, please contact:
|
|
|
|
Dr |
Tel: +44 (0) 1223 426060 Email: info@arecor.com |
|
|
Tel: +44 (0) 1223 426060 Email: info@arecor.com |
|
|
|
|
|
|
|
|
Tel: +44 (0) 20 7496 3000 |
|
|
|
|
|
|
|
|
Tel: +44 (0) 20 3709 5700 Email: arecor@icrhealthcare.com |
Notes to Editors
About Arecor
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
|
a) |
|
|
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chair |
|
b) |
Initial notification/Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
|
|
|
b) |
LEI |
98450093D1213A8DDD58 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares |
|
b) |
Identification Code |
GB00BMWLM973 |
|
c) |
Nature of the transaction |
Purchase of Ordinary Shares |
|
d) |
Price(s) and volume(s) |
£0.4697 and 31,750 Ordinary Shares |
|
e) |
Aggregated information - Aggregated volume - Aggregated price |
N/A |
|
f) |
Date of the transaction |
|
|
g) |
Place of the transaction |
|
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
|
a) |
|
|
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chief Executive Officer |
|
b) |
Initial notification/Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
|
|
|
b) |
LEI |
98450093D1213A8DDD58 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares |
|
b) |
Identification Code |
GB00BMWLM973 |
|
c) |
Nature of the transaction |
Purchase of Ordinary Shares |
|
d) |
Price(s) and volume(s) |
£0.4697 and 21,077 Ordinary Shares |
|
e) |
Aggregated information - Aggregated volume - Aggregated price |
N/A |
|
f) |
Date of the transaction |
|
|
g) |
Place of the transaction |
|
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
|
a) |
|
|
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chief Scientific Officer |
|
b) |
Initial notification/Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
|
|
|
b) |
LEI |
98450093D1213A8DDD58 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares |
|
b) |
Identification Code |
GB00BMWLM973 |
|
c) |
Nature of the transaction |
Purchase of Ordinary Shares |
|
d) |
Price(s) and volume(s) |
£0.4700 and 10,000 Ordinary Shares |
|
e) |
Aggregated information - Aggregated volume - Aggregated price |
N/A |
|
f) |
Date of the transaction |
|
|
g) |
Place of the transaction |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the